An Analytical Study of Financial Efficiency and Profitability in Leading Indian Pharmaceutical Companies

This study examines the financial efficiency and profitability of leading Indian pharmaceutical companies over the period 2021–2025, focusing on key indicators such as revenue, net profit, return on equity, tax, and enterprise valuation (EV/EBITDA). Using secondary data from verified financial sources and applying statistical tools like descriptive analysis and one-way ANOVA, the research identifies patterns, similarities, and differences in performance across the selected firms. The findings show that while revenue, profitability, and valuation remain relatively stable, differences in tax payments indicate variations in financial management and efficiency. The study highlights the importance of strategic measures such as cost optimization, effective use of intellectual capital, and innovation-driven growth to improve financial performance, offering practical insights for managers and policymakers to strengthen competitiveness and ensure sustainable value creation in the pharmaceutical sector.